tradingkey.logo

10X Genomics Inc

TXG
View Detailed Chart

11.920USD

-1.090-8.38%
Close 07/07, 16:00ETQuotes delayed by 15 min
1.47BMarket Cap
LossP/E TTM

10X Genomics Inc

11.920

-1.090-8.38%
Intraday
1m
30m
1h
D
W
M
D

Today

-8.38%

5 Days

+2.94%

1 Month

+26.54%

6 Months

-23.25%

Year to Date

-16.99%

1 Year

-36.32%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 18 analysts
BUY
Current Rating
13.308
Target Price
2.29%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

113
Total
7
Median
9
Average
Company name
Ratings
Analysts
10X Genomics Inc
TXG
18
Medtronic PLC
MDT
34
Stryker Corp
SYK
33
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
Dexcom Inc
DXCM
28
1
2
3
...
23

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(5)
Neutral(2)
Buy(6)
Indicators
Sell(3)
Neutral(2)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.199
Buy
RSI(14)
60.535
Neutral
STOCH(KDJ)(9,3,3)
71.565
Sell
ATR(14)
0.763
Low Volatility
CCI(14)
75.984
Neutral
Williams %R
41.077
Buy
TRIX(12,20)
1.178
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
12.316
Sell
MA10
11.835
Buy
MA20
11.177
Buy
MA50
9.749
Buy
MA100
9.812
Buy
MA200
13.025
Sell

News

More news coming soon, stay tuned...

Company

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Ticker SymbolTXG
Company10X Genomics Inc
CEOMr. Serge Wilson Saxonov, Ph.D.
Websitehttps://www.10xgenomics.com/
KeyAI